Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Stem Cells and Development|September 23, 2014
Do human leukocyte antigen-typed cellular therapeutics based on induced pluripotent stem cells make commercial sense?Christopher A BraveryJournal of the Royal Society, Interface|September 24, 2010
Regulating interface science healthcare products: myths and uncertaintiesChristopher A BraveryCytotherapy|July 29, 2014
Reference materials for cellular therapeuticsChristopher A Bravery, Anna FrenchMolecular Therapy. Methods & Clinical Development|July 9, 2020
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other BiologicalsMagdi Elsallab, Christopher A Bravery, Andreas Kurtz, et al.Experimental Physiology|November 7, 2006
Increasing renal mass improves survival in anephric rats following metanephros transplantationDamian Marshall, Mark R Dilworth, Marc Clancy, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2007
Development and functional capacity of transplanted rat metanephroiMark Robert Dilworth, Marc James Clancy, Damian Marshall, et al.Cytotherapy|December 25, 2012
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industryChristopher A Bravery, Jessica Carmen, Timothy Fong, et al.Pageof 1